MacroGenics rises ~15% on licensing deal with Gilead for potential cancer treatment
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
3,235$
0,77%
Echtzeit-Aktienkurs MacroGenics Inc.
Bid:
Ask:
Nachrichten zur MacroGenics Inc. Aktie
Gilead, MacroGenics In Deal To Develop Bispecific Antibodies
FOSTER CITY (dpa-AFX) - Biopharmaceutical companies Gilead Sciences, Inc. (GILD) and MacroGenics (MGNX) announced Monday an exclusive option and collaboration…
MacroGenics in Collaboration Agreement With Gilead Sciences for MGD024
MacroGenics in Collaboration Agreement With Gilead Sciences for MGD024...…